{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T04:24:06Z","timestamp":1789619046646,"version":"build-2803163510"},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.pharma.2025.08.006","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T05:07:55Z","timestamp":1755493675000},"page":"124-140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Optimization of UV spectrophotometric techniques for tafamidis meglumine detection in pharmaceutical formulations and biological samples: A green chemistry perspective"],"prefix":"10.1016","volume":"84","author":[{"given":"Md. Mojeeb G.","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubham R.","family":"Raut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Rageeb Md.","family":"Usman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul A.","family":"Shirkhedkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Shamsher","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7649-9413","authenticated-orcid":false,"given":"Zamir G.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharma.2025.08.006_bib0230","series-title":"Tafamidis FDA approval summary","year":"2019"},{"issue":"11","key":"10.1016\/j.pharma.2025.08.006_bib0235","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharma.2025.08.006_bib0240","series-title":"Highlights of prescribing information: Vyndaqel and Vyndamax","year":"2019"},{"issue":"1","key":"10.1016\/j.pharma.2025.08.006_bib0245","doi-asserted-by":"crossref","first-page":"e008193","DOI":"10.1161\/CIRCHEARTFAILURE.120.008193","article-title":"Long-term survival with tafamidis in patients with transthyretin amyloid cardiomyopathy","volume":"15","author":"Elliott","year":"2022","journal-title":"Circ Heart Fail"},{"issue":"4","key":"10.1016\/j.pharma.2025.08.006_bib0250","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1002\/ehf2.14380","article-title":"Clinical characteristics, outcome, and therapeutic effect of tafamidis in wild-type transthyretin amyloid cardiomyopathy","volume":"10","author":"Takashio","year":"2023","journal-title":"ESC Heart Fail"},{"issue":"1","key":"10.1016\/j.pharma.2025.08.006_bib0255","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jchf.2023.08.032","article-title":"Tafamidis efficacy among octogenarian patients in the phase 3 ATTR-ACT and ongoing long-term extension study","volume":"12","author":"Garcia-Pavia","year":"2024","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.pharma.2025.08.006_bib0260","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jpba.2017.01.020","article-title":"Development and validation of a liquid chromatography-tandem mass spectrometry method for the assay of tafamidis in rat plasma: application to a pharmacokinetic study in rats","volume":"137","author":"Hyun","year":"2017","journal-title":"J Pharm Biomed Anal"},{"issue":"9","key":"10.1016\/j.pharma.2025.08.006_bib0265","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1093\/chromsci\/bmab132","article-title":"Determination of tafamidis plasma concentrations in amyloidosis patients with Glu89Gln mutation by HPLC-UV detection","volume":"60","author":"Smerikarova","year":"2022","journal-title":"J Chromatogr Sci"},{"key":"10.1016\/j.pharma.2025.08.006_bib0270","doi-asserted-by":"crossref","first-page":"101321","DOI":"10.1016\/j.scp.2023.101321","article-title":"A green sustainable ultrasensitive micelle-sensitized spectrofluorimetric approach for the estimation of tafamidis in different matrices at picogram levels","volume":"36","author":"Alossaimi","year":"2023","journal-title":"Sustain Chem Pharm"},{"key":"10.1016\/j.pharma.2025.08.006_bib0275","doi-asserted-by":"crossref","first-page":"122289","DOI":"10.1016\/j.ijpharm.2022.122289","article-title":"UV-responsive fluorescent behavior of pharmaceuticals assessed by UV-induced fingerprint spectroscopy (UV-IFS)","volume":"628","author":"Pavelicova","year":"2022","journal-title":"Int J Pharm"},{"issue":"26","key":"10.1016\/j.pharma.2025.08.006_bib0280","doi-asserted-by":"crossref","first-page":"28776","DOI":"10.1021\/acsomega.4c03172","article-title":"First-order derivative spectrophotometry for simultaneous determination of vitamin C and nicotinamide: application in quantitative analysis of cocrystals","volume":"9","author":"Balbinot Filho","year":"2024","journal-title":"ACS Omega"},{"issue":"3","key":"10.1016\/j.pharma.2025.08.006_bib0285","doi-asserted-by":"crossref","first-page":"e14189","DOI":"10.1016\/j.heliyon.2023.e14189","article-title":"A new method for simultaneous qualitative and quantitative determination of amlodipine besylate and atorvastatin calcium in bulk and pharmaceutical formulations using transmission FT-IR spectroscopy","volume":"9","author":"Ibesh","year":"2023","journal-title":"Heliyon"},{"issue":"7","key":"10.1016\/j.pharma.2025.08.006_bib0290","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.2174\/1386207323666201207114302","article-title":"Validation of an UPLC-DAD method for the quantification of phenolic acids, verbascoside and 6-epi-aucubin in Crescentia cujete fruit","volume":"25","author":"Rivera-Mondrag\u00f3n","year":"2022","journal-title":"Comb Chem High Throughput Screen"},{"issue":"2","key":"10.1016\/j.pharma.2025.08.006_bib0295","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/jaoacint\/qsab151","article-title":"Validated spectrophotometric methods for simultaneous determination of atorvastatin calcium and olmesartan medoxomil in their pharmaceutical formulation","volume":"105","author":"Kamal","year":"2022","journal-title":"J AOAC Int"},{"issue":"1","key":"10.1016\/j.pharma.2025.08.006_bib0300","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/chromsci\/bmab030","article-title":"Quality-by-design approach for chromatographic analysis of metformin, empagliflozin and linagliptin","volume":"60","author":"Gurrala","year":"2022","journal-title":"J Chromatogr Sci"},{"issue":"4","key":"10.1016\/j.pharma.2025.08.006_bib0305","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.5740\/jaoacint.17-0363","article-title":"Are LOD and LOQ reliable parameters for sensitivity evaluation of spectroscopic methods","volume":"101","author":"Ershadi","year":"2018","journal-title":"J AOAC Int"},{"issue":"10","key":"10.1016\/j.pharma.2025.08.006_bib0310","first-page":"40","article-title":"Recent development in ultraviolet spectrophotometry through the last decade (2006\u20132016): a review","volume":"8","author":"Lotfy","year":"2016","journal-title":"Int J Pharmacogn Phytochem Res"},{"issue":"2","key":"10.1016\/j.pharma.2025.08.006_bib0315","first-page":"348","article-title":"A review on UV spectrophotometric methods for simultaneous multicomponent analysis","volume":"3","author":"Kamal","year":"2016","journal-title":"Eur J Pharm Med Res"},{"issue":"7","key":"10.1016\/j.pharma.2025.08.006_bib0320","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.3390\/md10071459","article-title":"The use of UV-visible reflectance spectroscopy as an objective tool to evaluate pearl quality","volume":"10","author":"Agatonovic-Kustrin","year":"2012","journal-title":"Mar Drugs"},{"key":"10.1016\/j.pharma.2025.08.006_bib0325","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.saa.2014.11.049","article-title":"FT-IR, FT-Raman, UV-visible, and NMR spectroscopy and vibrational properties of the labdane-type diterpene 13-epi-sclareol","volume":"138","author":"Chain","year":"2015","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"key":"10.1016\/j.pharma.2025.08.006_bib0330","doi-asserted-by":"crossref","first-page":"115169","DOI":"10.1016\/j.jpba.2022.115169","article-title":"UV-visible absorption spectroscopy for in-line API concentration measurement in nanoparticle production process using controlled expansion of supercritical solutions (CESS\u00ae)","volume":"224","author":"Kauppinen","year":"2023","journal-title":"J Pharm Biomed Anal"},{"issue":"35","key":"10.1016\/j.pharma.2025.08.006_bib0335","doi-asserted-by":"crossref","first-page":"12998","DOI":"10.1021\/acs.analchem.3c01649","article-title":"Molecular surface quantification of multifunctionalized gold nanoparticles using UV-visible absorption spectroscopy deconvolution","volume":"95","author":"Potts","year":"2023","journal-title":"Anal Chem"},{"key":"10.1016\/j.pharma.2025.08.006_bib0340","doi-asserted-by":"crossref","first-page":"122512","DOI":"10.1016\/j.jchromb.2020.122512","article-title":"Validation of a HPLC-UV method for the quantification of budesonide in skin layers","volume":"1164","author":"Demurtas","year":"2021","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"3","key":"10.1016\/j.pharma.2025.08.006_bib0345","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/jssc.201300845","article-title":"Reliability-targeted HPLC-UV method validation\u00a0\u2013\u00a0a protocol enrichment perspective","volume":"37","author":"Dharuman","year":"2014","journal-title":"J Sep Sci"},{"issue":"9","key":"10.1016\/j.pharma.2025.08.006_bib0350","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1055\/a-1217-0296","article-title":"Analytical method development and validation of UV-visible spectrophotometric method for the estimation of vildagliptin in gastric medium","volume":"70","author":"Kumari","year":"2020","journal-title":"Drug Res"},{"issue":"11","key":"10.1016\/j.pharma.2025.08.006_bib0355","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.3390\/molecules27113587","article-title":"Development and Validation of an HPLC-UV Method for the Quantification of 4\u2032-Hydroxydiclofenac Using Salicylic Acid: Future Applications for Measurement of In Vitro Drug\u2013Drug Interaction in Rat Liver Microsomes","volume":"27","author":"Salhab","year":"2022","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.pharma.2025.08.006_bib0360","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1093\/chromsci\/bmac108","article-title":"HPLC-UV method development and validation to monitor difluprednate synthesis","volume":"61","author":"Sammut Bartolo","year":"2023","journal-title":"J Chromatogr Sci"},{"issue":"1","key":"10.1016\/j.pharma.2025.08.006_bib0365","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13065-022-00809-x","article-title":"Development and validation of derivative UV spectroscopic method for simultaneous estimation of nicotinamide and tretinoin in their binary mixtures and pharmaceutical preparations","volume":"16","author":"Sarkis","year":"2022","journal-title":"BMC Chem"},{"key":"10.1016\/j.pharma.2025.08.006_bib0370","doi-asserted-by":"crossref","first-page":"124689","DOI":"10.1016\/j.saa.2024.124689","article-title":"Spectrophotometric and chromatographic analysis of creatine:creatinine crystals in urine","volume":"322","author":"Werle","year":"2024","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"key":"10.1016\/j.pharma.2025.08.006_bib0375","doi-asserted-by":"crossref","first-page":"101796","DOI":"10.1016\/j.scp.2024.101796","article-title":"Innovative five eco-friendly spectrophotometric methods for simultaneous determination of the recently FDA-approved combination, dextromethorphan and bupropion in co-formulated tablets and biological fluids","volume":"42","author":"Radwan","year":"2024","journal-title":"Sustain Chem Pharm"},{"key":"10.1016\/j.pharma.2025.08.006_bib0380","doi-asserted-by":"crossref","first-page":"101469","DOI":"10.1016\/j.scp.2024.101469","article-title":"Eco-friendly chromatographic techniques for appraisal of amlodipine, hydrochlorothiazide, telmisartan, and their related substances in dosage form: Application to six sigma and content uniformity approaches","volume":"38","author":"Ahmed","year":"2024","journal-title":"Sustain Chem Pharm"},{"key":"10.1016\/j.pharma.2025.08.006_bib0385","doi-asserted-by":"crossref","first-page":"101463","DOI":"10.1016\/j.scp.2024.101463","article-title":"Greenness, blueness and whiteness evaluated-chemometric approach enhanced by Latin hypercube technique for the analysis of lidocaine, diclofenac and carcinogenic impurity 2, 6-dimethylaniline","volume":"38","author":"Halim","year":"2024","journal-title":"Sustain Chem Pharm"},{"key":"10.1016\/j.pharma.2025.08.006_bib0390","doi-asserted-by":"crossref","first-page":"100140","DOI":"10.1016\/j.greeac.2024.100140","article-title":"Greenness metrics for analytical methodologies linked to mass spectrometry","volume":"10","author":"Jurisch","year":"2024","journal-title":"Green Analytical Chemistry"},{"issue":"4","key":"10.1016\/j.pharma.2025.08.006_bib0395","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1080\/10408347.2024.2304552","article-title":"Assessing the greenness and environmental friendliness of analytical methods: modern approaches and recent computational programs","volume":"55","author":"Semysim","year":"2024","journal-title":"Crit Rev Anal Chem"},{"key":"10.1016\/j.pharma.2025.08.006_bib0400","series-title":"Green analytical chemistry metrics. Green analytical methods and miniaturized sample preparation techniques for forensic drug analysis","first-page":"23","author":"Sajid","year":"2025"},{"key":"10.1016\/j.pharma.2025.08.006_bib0405","doi-asserted-by":"crossref","first-page":"117598","DOI":"10.1016\/j.trac.2024.117598","article-title":"Green metrics for analytical methodologies: uncovering sustainable chromatography approaches for detecting emerging contaminants in food and environmental water","volume":"172","author":"Hashim","year":"2024","journal-title":"Trends Analyt Chem"},{"key":"10.1016\/j.pharma.2025.08.006_bib0410","doi-asserted-by":"crossref","first-page":"100182","DOI":"10.1016\/j.greeac.2024.100182","article-title":"Assessing environmental sustainability of HPLC methods for tri-combination anti-hypertensive drug analysis","volume":"12","author":"Pragathi","year":"2025","journal-title":"Green Anal Chem"},{"issue":"1","key":"10.1016\/j.pharma.2025.08.006_bib0415","first-page":"19","article-title":"Determination of azole antifungal medicines using zero-order and derivative UV spectrophotometry","volume":"66","author":"Ekiert","year":"2009","journal-title":"Acta Pol Pharm"},{"key":"10.1016\/j.pharma.2025.08.006_bib0420","doi-asserted-by":"crossref","first-page":"19999","DOI":"10.1016\/j.saa.2021.119999","article-title":"Mathematical filtration of quaternary mixture to the zero order spectra of its individual components","volume":"261","author":"Fahmy","year":"2021","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"issue":"6","key":"10.1016\/j.pharma.2025.08.006_bib0425","first-page":"421","article-title":"Determination of lornoxicam in pharmaceutical preparations by zero and first order derivative UV spectrophotometric methods","volume":"60","author":"Nemutlu","year":"2005","journal-title":"Pharmazie"},{"key":"10.1016\/j.pharma.2025.08.006_bib0430","doi-asserted-by":"crossref","first-page":"119682","DOI":"10.1016\/j.saa.2021.119682","article-title":"Simultaneous determination of dorzolamide and timolol by first-order derivative UV spectroscopy in simulated biological fluid for in vitro drug release testing","volume":"255","author":"Tambe","year":"2021","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"issue":"18","key":"10.1016\/j.pharma.2025.08.006_bib0435","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1002\/jssc.202000510","article-title":"A multivariate quantification of Box-Behnken design assisted method development and validation of dextromethorphan hydrobromide and desloratadine simultaneously by reverse-phase HPLC in in-house syrup formulation","volume":"43","author":"Alam","year":"2020","journal-title":"J Sep Sci"},{"issue":"1","key":"10.1016\/j.pharma.2025.08.006_bib0440","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11095-023-03609-7","article-title":"Development and validation of discriminatory in-vitro release method for intramammary drug product","volume":"41","author":"Helal","year":"2024","journal-title":"Pharm Res"},{"issue":"3","key":"10.1016\/j.pharma.2025.08.006_bib0445","first-page":"180","article-title":"Development and Validation of chromatographic method for the standardization of homeopathic formulation of Syzygium cumini","volume":"110","author":"Mishra","year":"2021","journal-title":"Homeopathy"},{"key":"10.1016\/j.pharma.2025.08.006_bib0450","doi-asserted-by":"crossref","first-page":"5570173","DOI":"10.1155\/2021\/5570173","article-title":"A RP-HPLC method for the analysis of neostigmine methylsulfate and process-related impurities, forced degradation studies, in the injection formulation","volume":"2021","author":"Parab","year":"2021","journal-title":"Int J Anal Chem"}],"container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450925001294?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450925001294?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T00:57:04Z","timestamp":1766192224000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003450925001294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0003450925001294"],"URL":"https:\/\/doi.org\/10.1016\/j.pharma.2025.08.006","relation":{},"ISSN":["0003-4509"],"issn-type":[{"value":"0003-4509","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimization of UV spectrophotometric techniques for tafamidis meglumine detection in pharmaceutical formulations and biological samples: A green chemistry perspective","name":"articletitle","label":"Article Title"},{"value":"Annales Pharmaceutiques Fran\u00e7aises","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharma.2025.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Acad\u00e9mie Nationale de Pharmacie. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}